VistaGen Therapeutics
VTGN
VTGN
93 hedge funds and large institutions have $9.13M invested in VistaGen Therapeutics in 2022 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 33 increasing their positions, 27 reducing their positions, and 36 closing their positions.
Holders
93
Holders Change
-19
Holders Change %
-16.96%
% of All Funds
1.61%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
17
Increased
33
Reduced
27
Closed
36
Calls
$422K
Puts
$19K
Net Calls
+$403K
Net Calls Change
-$665K
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CM
126
Crestline Management
Fort Worth,
Texas
| – | – | – | – |
|
|
CFGS
127
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
GI
128
Gradient Investments
Arden Hills,
Minnesota
| $0 | 1 | – | – |
|
|
SM
129
Sabby Management
Miami Beach,
Florida
| – | – | – | – |
|
130
Royal Bank of Canada
Toronto,
Ontario, Canada
| $0 | 79 | +9 | +13% |
|
|
SSG
131
Summit Securities Group
New York
| $0 | 18 | +18 | New |
|
|
CS
132
Credit Suisse
Zurich,
Switzerland
| $0 | 76 | +73 | +2,433% |
|